Context Therapeutics Inc. (CNTX) earnings
Quarterly results of Context Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Context Therapeutics Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Context Therapeutics Inc. reported revenue of - and a net loss of $14.6M.
Diluted earnings per share were -$0.15.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$14.6M | -$0.15 |
| Q1 FY2026 | - | - | -$8.7M | -$0.09 |
| Q4 FY2025 | - | - | -$13M | - |
| Q3 FY2025 | - | - | -$9.7M | -$0.10 |
| Q2 FY2025 | - | - | -$8.8M | -$0.09 |
| Q1 FY2025 | - | - | -$4.6M | -$0.05 |
| Q4 FY2024 | - | - | -$3.3M | - |
| Q3 FY2024 | - | - | -$17.5M | -$0.22 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
When is Context Therapeutics Inc.'s next earnings date?
Context Therapeutics Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Get an email when CNTX reports
Follow CNTX and we email you its next results the day they are filed, with the numbers explained.